• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-肾上腺素能受体阻断后大鼠心脏α1-肾上腺素能受体密度变化的时程和程度

Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.

作者信息

Steinkraus V, Nose M, Scholz H, Thormählen K

机构信息

Abteilung Allgemeine Pharmakologie, Universitäts-Krankenhaus Eppendorf, Universität Hamburg, F.R.G.

出版信息

Br J Pharmacol. 1989 Feb;96(2):441-9. doi: 10.1111/j.1476-5381.1989.tb11836.x.

DOI:10.1111/j.1476-5381.1989.tb11836.x
PMID:2564293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1854362/
Abstract
  1. It has been suggested that impaired beta-adrenoceptor stimulation is a condition under which the functional role of cardiac alpha 1-adrenoceptors is enhanced. We therefore investigated the extent and time course of changes in alpha 1-adrenoceptor characteristics after chronic treatment with the beta-adrenoceptor blocker propranolol in rat heart. For comparison beta-adrenoceptors were also studied. The mechanism of the changes in adrenoceptor density was investigated with cycloheximide, an inhibitor of protein synthesis. The functional significance of an increased alpha 1-adrenoceptor density was tested by measuring isometric force of contraction in the presence of phenylephrine or isoprenaline in right ventricular papillary muscles. 2. Rats were treated with propranolol (9.9 mg kg-1 daily) or 0.9% NaCl, applied with osmotic minipumps for 1, 2, 3 or 7 days. Propranolol treatment resulted in a maximally 28% increase of alpha 1-adrenoceptor density after 3 days (NaCl 95.9 +/- 3.5 vs. propranolol 123.0 +/- 1.6 fmol mg-1 protein, n = 6, P less than 0.01). This up regulation reached significant levels after 2 days of treatment and was reversible after cessation of treatment within two days. KD-values were the same for NaCl- and propranolol-treated rats. Changes of Bmax and KD in beta-adrenoceptor binding assays did not reach significant levels. 3. Cycloheximide (1.5 mg kg-1 i.p. daily for 3 days) inhibited the propranolol-induced increase in Bmax of alpha 1-adrenoceptors completely. In addition, cycloheximide also decreased the density of alpha 1- and beta-adrenoceptors also under control conditions. 4. pD2-values for the positive inotropic effect of phenylephrine and isoprenaline in isolated electrically driven papillary muscle were similar in NaCl- and propranolol-treated rats (phenylephrine: 5.41 + 0.11 vs. 5.41 + 0.19, n = 7; isoprenaline: 6.31 + 0.18 vs. 6.65 + 0.19, n = 7). The observed increase in alpha-adrenoceptor density in healthy rat heart may therefore not be high enough to enhance the phenylephrine-induced increase in force of contraction. 5. In conclusion, time course and effects of cycloheximide indicate that the increase in B,,,, of myocardial alpha 1-adrenoceptors is due to de novo synthesis of receptors. However, at least for the rat heart model, a functional significance of this increase could not be demonstrated.
摘要
  1. 有人提出,β-肾上腺素能受体刺激受损是一种心脏α1-肾上腺素能受体功能作用增强的状态。因此,我们研究了用β-肾上腺素能受体阻滞剂普萘洛尔长期治疗大鼠心脏后α1-肾上腺素能受体特性变化的程度和时间进程。为作比较,也对β-肾上腺素能受体进行了研究。用蛋白质合成抑制剂环己酰亚胺研究了肾上腺素能受体密度变化的机制。通过测量右心室乳头肌在去氧肾上腺素或异丙肾上腺素存在下的等长收缩力,测试了α1-肾上腺素能受体密度增加的功能意义。2. 大鼠用普萘洛尔(每日9.9毫克/千克)或0.9%氯化钠处理,通过渗透微型泵给药1、2、3或7天。普萘洛尔处理3天后,α1-肾上腺素能受体密度最大增加28%(氯化钠组95.9±3.5对普萘洛尔组123.0±1.6飞摩尔/毫克蛋白质,n = 6,P<0.01)。这种上调在治疗2天后达到显著水平,停药后两天内可逆转。氯化钠处理和普萘洛尔处理的大鼠的KD值相同。β-肾上腺素能受体结合试验中Bmax和KD的变化未达到显著水平。3. 环己酰亚胺(每日腹腔注射1.5毫克/千克,共3天)完全抑制了普萘洛尔诱导的α1-肾上腺素能受体Bmax增加。此外,环己酰亚胺在对照条件下也降低了α1-和β-肾上腺素能受体的密度。4. 去氧肾上腺素和异丙肾上腺素对离体电驱动乳头肌正性肌力作用的pD2值在氯化钠处理和普萘洛尔处理的大鼠中相似(去氧肾上腺素:5.41±0.11对5.41±0.19,n = 7;异丙肾上腺素:6.31±0.18对6.65±0.19,n = 7)。因此,在健康大鼠心脏中观察到的α-肾上腺素能受体密度增加可能不足以增强去氧肾上腺素诱导的收缩力增加。5. 总之,环己酰亚胺的时间进程和作用表明,心肌α1-肾上腺素能受体Bmax的增加是由于受体的从头合成。然而,至少对于大鼠心脏模型,这种增加的功能意义未能得到证实。

相似文献

1
Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.β-肾上腺素能受体阻断后大鼠心脏α1-肾上腺素能受体密度变化的时程和程度
Br J Pharmacol. 1989 Feb;96(2):441-9. doi: 10.1111/j.1476-5381.1989.tb11836.x.
2
Whether phenylephrine exerts inotropic effects through alpha- or beta-adrenoceptors depends upon the relative receptor populations.去氧肾上腺素是通过α-肾上腺素能受体还是β-肾上腺素能受体发挥变力作用,取决于相对的受体数量。
Fundam Clin Pharmacol. 1990;4(1):25-37. doi: 10.1111/j.1472-8206.1990.tb01014.x.
3
Differences between alpha-adrenergic and beta-adrenergic inotropic effects in rat heart papillary muscles.大鼠心脏乳头肌中α-肾上腺素能与β-肾上腺素能变力作用的差异。
Acta Pharmacol Toxicol (Copenh). 1982 Jan;50(1):1-12. doi: 10.1111/j.1600-0773.1982.tb00932.x.
4
Properties of cardiac alpha- and beta-adrenoceptors in spontaneously hypertensive rats.自发性高血压大鼠心脏α和β肾上腺素能受体的特性
Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):383-91. doi: 10.1007/BF00172114.
5
Altered alpha 1-adrenoceptor subtypes mediated cardiac function after treatment of propranolol to rats.普萘洛尔处理大鼠后,α1 -肾上腺素能受体亚型改变介导心脏功能。
Zhongguo Yao Li Xue Bao. 1997 May;18(3):237-40.
6
Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.大鼠心脏左右心房中β1和β2肾上腺素能受体结合及功能反应
Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):193-202. doi: 10.1007/BF00572434.
7
Preponderance of beta- over alpha-adrenoceptors in mediating the positive inotropic effect of phenylephrine in the ferret ventricular myocardium.在介导去氧肾上腺素对雪貂心室肌的正性肌力作用方面,β-肾上腺素能受体比α-肾上腺素能受体占优势。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Mar;339(3):362-6. doi: 10.1007/BF00173593.
8
Interaction between Na+/phosphate-cotransporter and the adrenoceptors in myocardial depression.心肌抑制中钠/磷酸盐共转运体与肾上腺素能受体之间的相互作用。
J Cardiovasc Pharmacol. 1998 Jan;31(1):10-7. doi: 10.1097/00005344-199801000-00002.
9
Induction by endogenous noradrenaline of an alpha 1-adrenoceptor-mediated positive inotropic effect in rabbit papillary muscles.内源性去甲肾上腺素诱导兔乳头肌中α1 -肾上腺素能受体介导的正性肌力作用。
Br J Pharmacol. 1993 Aug;109(4):1232-8. doi: 10.1111/j.1476-5381.1993.tb13754.x.
10
Potentiation of alpha-adrenoceptor-mediated responses following chronic beta-adrenoceptor stimulation in the rat heart.大鼠心脏慢性β-肾上腺素能受体刺激后α-肾上腺素能受体介导反应的增强
Br J Pharmacol. 1993 Mar;108(3):658-62. doi: 10.1111/j.1476-5381.1993.tb12857.x.

引用本文的文献

1
Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen.在控制饮食方案下,第三代β受体阻滞剂对超重-肥胖人群体重减轻的影响。
J Nutr Metab. 2021 Sep 23;2021:5767306. doi: 10.1155/2021/5767306. eCollection 2021.
2
Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior.突触后α-2肾上腺素能受体对于地昔帕明的抗抑郁样行为效应至关重要。
Neuropsychopharmacology. 2009 Mar;34(4):1067-77. doi: 10.1038/npp.2008.184. Epub 2008 Oct 15.
3
Cloning and characterization of a complementary DNA for a thyroid hormone-responsive protein in mature rat cerebral tissue.成熟大鼠脑组织中甲状腺激素反应蛋白互补DNA的克隆与特性分析
Biochem J. 1997 Oct 15;327 ( Pt 2)(Pt 2):617-23. doi: 10.1042/bj3270617.
4
Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors.CGP 12177用于β-肾上腺素能受体体内研究的适用性证明。
Br J Pharmacol. 1993 Aug;109(4):1101-9. doi: 10.1111/j.1476-5381.1993.tb13736.x.
5
Potentiation of alpha-adrenoceptor-mediated responses following chronic beta-adrenoceptor stimulation in the rat heart.大鼠心脏慢性β-肾上腺素能受体刺激后α-肾上腺素能受体介导反应的增强
Br J Pharmacol. 1993 Mar;108(3):658-62. doi: 10.1111/j.1476-5381.1993.tb12857.x.
6
Cardiac alpha 1-adrenoceptor densities in different mammalian species.不同哺乳动物物种的心脏α1-肾上腺素能受体密度
Br J Pharmacol. 1992 Sep;107(1):185-8. doi: 10.1111/j.1476-5381.1992.tb14484.x.
7
Electrophysiologic and inotropic effects of alpha-adrenoceptor stimulation in human isolated atrial heart muscle.α-肾上腺素能受体刺激对人离体心房肌的电生理和变力效应。
Naunyn Schmiedebergs Arch Pharmacol. 1992 Jul;346(1):82-7. doi: 10.1007/BF00167575.
8
Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart.异丙肾上腺素诱导大鼠心脏中40/41 kDa百日咳毒素底物增加及其对收缩反应的功能影响。
Naunyn Schmiedebergs Arch Pharmacol. 1992 Jan;345(1):44-50. doi: 10.1007/BF00175468.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Differences in myocardial alpha- and beta-adrenergic receptor numbers in different species.不同物种中心肌α-和β-肾上腺素能受体数量的差异。
Am J Physiol. 1983 Dec;245(6):H957-61. doi: 10.1152/ajpheart.1983.245.6.H957.
3
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.衰竭的人类心脏中儿茶酚胺敏感性和β-肾上腺素能受体密度降低。
N Engl J Med. 1982 Jul 22;307(4):205-11. doi: 10.1056/NEJM198207223070401.
4
Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol.普萘洛尔长期治疗后大鼠淋巴细胞、心脏和肺中β肾上腺素能受体密度的变化。
J Pharmacol Exp Ther. 1982 May;221(2):439-43.
5
Effect of propranolol on beta-adrenoceptors in rat hearts.普萘洛尔对大鼠心脏β-肾上腺素能受体的作用。
Br J Pharmacol. 1980 Jan;68(1):8-10. doi: 10.1111/j.1476-5381.1980.tb10689.x.
6
Distribution and function of beta-adrenoceptors in different chambers of the canine heart.β-肾上腺素能受体在犬心脏不同腔室中的分布与功能
Br J Pharmacol. 1980 Jan;68(1):57-63. doi: 10.1111/j.1476-5381.1980.tb10698.x.
7
Ex vivo examination of beta-adrenoceptor characteristics after propranolol withdrawal.普萘洛尔撤药后β-肾上腺素能受体特征的体外研究
J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):701-6. doi: 10.1097/00005344-198407000-00024.
8
Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization.腺苷酸环化酶偶联的β-肾上腺素能受体:激活与脱敏的结构及机制
Annu Rev Biochem. 1983;52:159-86. doi: 10.1146/annurev.bi.52.070183.001111.
9
The classification of drugs and drug receptors in isolated tissues.离体组织中药物及药物受体的分类
Pharmacol Rev. 1984 Sep;36(3):165-222.
10
Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.腺苷对豚鼠心房和心室心脏标本中儿茶酚胺诱导的收缩力增加的抑制作用。反对环磷酸腺苷和环磷酸鸟苷依赖性效应的证据。
J Pharmacol Exp Ther. 1984 Aug;230(2):483-92.